Magnetocardiography (MCG) in Asymptomatic Individuals - Pilot Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00572442|
Recruitment Status : Withdrawn (sponsor funding)
First Posted : December 13, 2007
Last Update Posted : November 17, 2009
The purpose of this research study is to perform serial magnetocardiographs (MCG)and cardiovascular risk factor assessments on individuals with no symptoms or history of heart disease. This small sized study of MCG in healthy individuals will allow for data collection for power analysis for a larger prospective trial.
Volunteers are not compensated or paid.
|Condition or disease|
The Magnetocardiography (MCG) has been approved by the U.S Food and Drug Administration (FDA) as a tool to measure the heart's magnetic field.However, it is not yet approved for the specific diagnosis of coronary artery disease.
The MCG scan is entirely non-invasive, rapid and no risk, since it does not require stress provocation, radiation, or use of medication or contrast.
In this study, the MCG will be used to compare the scans of normal, healthy volunteers to those which have been previously or are currently being collected in subjects with known heart disease.
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Magnetocardiography (MCG) in Asymptomatic Individuals - Pilot Trial|
|Study Start Date :||December 2007|
|Estimated Primary Completion Date :||November 2009|
|Estimated Study Completion Date :||December 2009|
Subjects without any cardiovascular risk factors:
Subjects with 1 cardiovascular risk factor (listed above)
Subjects with 2 cardiovascular risk factors (listed above)
Subjects with more than 2 cardiovascular risk factors (listed above)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00572442
|United States, California|
|Cedars-Sinai Medical Center|
|Los Angeles, California, United States, 90048|
|Principal Investigator:||Kirsten Tolstrup, MD||Cedars-Sinai Medical Center|